NO20031650D0 - Nye legemidler for leversykdommer - Google Patents

Nye legemidler for leversykdommer

Info

Publication number
NO20031650D0
NO20031650D0 NO20031650A NO20031650A NO20031650D0 NO 20031650 D0 NO20031650 D0 NO 20031650D0 NO 20031650 A NO20031650 A NO 20031650A NO 20031650 A NO20031650 A NO 20031650A NO 20031650 D0 NO20031650 D0 NO 20031650D0
Authority
NO
Norway
Prior art keywords
liver diseases
new medicines
mcp
function inhibitors
medicines
Prior art date
Application number
NO20031650A
Other languages
English (en)
Other versions
NO20031650L (no
Inventor
Egashira Kensuke
Akira Takeshita
Masamichi Koyanagi
Makoto Nakamuta
Ken-Ishi Nishida
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20031650D0 publication Critical patent/NO20031650D0/no
Publication of NO20031650L publication Critical patent/NO20031650L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20031650A 2000-10-11 2003-04-10 Nye legemidler for leversykdommer NO20031650L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000310604 2000-10-11
PCT/JP2001/008552 WO2002030464A1 (fr) 2000-10-11 2001-09-28 Nouveaux medicaments pour maladies du foie

Publications (2)

Publication Number Publication Date
NO20031650D0 true NO20031650D0 (no) 2003-04-10
NO20031650L NO20031650L (no) 2003-06-05

Family

ID=18790533

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031650A NO20031650L (no) 2000-10-11 2003-04-10 Nye legemidler for leversykdommer

Country Status (8)

Country Link
US (1) US7335647B2 (no)
EP (1) EP1325751A4 (no)
JP (1) JPWO2002030464A1 (no)
CN (1) CN1469756A (no)
AU (1) AU2001292301A1 (no)
CA (1) CA2425765A1 (no)
NO (1) NO20031650L (no)
WO (1) WO2002030464A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002213441B2 (en) 2000-10-12 2006-10-26 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US7304040B2 (en) * 2001-11-02 2007-12-04 Kensuke Egashira Suppression of post-transplant arteriosclerosis
AU2003302755B2 (en) * 2002-12-23 2009-01-08 Laboratoires Serono Sa Use of CC-chemokine mutants against liver diseases
ZA200507757B (en) 2003-04-04 2007-01-31 Genentech Inc High concentration antibody and protein formulations
JP2010505878A (ja) * 2006-10-05 2010-02-25 セントコア・オーソ・バイオテツク・インコーポレーテツド 線維症の処置のためのｃｃｒ２アンタゴニスト
US20100130408A1 (en) * 2006-10-12 2010-05-27 Motoyuki Kohjima Use of modified cyclosporins
RU2011140498A (ru) 2009-03-06 2013-04-20 Дженентек, Инк. Препарат антител

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5739103A (en) 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
US5459128A (en) 1993-11-12 1995-10-17 Dana-Farber Cancer Institute Human monocyte chemoattractant protein-1 (MCP-1) derivatives
JP3720861B2 (ja) * 1994-10-21 2005-11-30 帝人株式会社 プロスタグランジン類およびその製造法
GB9501683D0 (en) 1995-01-27 1995-03-15 Glaxo Group Ltd Substances and their uses
JPH0967399A (ja) 1995-08-30 1997-03-11 Mitsui Toatsu Chem Inc 抗ｍｃｐ−１ヒトモノクローナル抗体
US6184235B1 (en) 1996-08-14 2001-02-06 Warner-Lambert Company 2-phenyl benzimidazole derivatives as MCP-1 antagonists
GB9716656D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
JPH1160502A (ja) * 1997-08-12 1999-03-02 Teijin Ltd 脳梗塞症治療薬もしくは予防薬
JP2000239182A (ja) * 1999-02-19 2000-09-05 Mitsubishi Chemicals Corp 抗炎症剤

Also Published As

Publication number Publication date
CN1469756A (zh) 2004-01-21
JPWO2002030464A1 (ja) 2004-02-19
US7335647B2 (en) 2008-02-26
CA2425765A1 (en) 2003-04-11
WO2002030464A1 (fr) 2002-04-18
EP1325751A4 (en) 2005-05-04
NO20031650L (no) 2003-06-05
US20050053603A1 (en) 2005-03-10
AU2001292301A1 (en) 2002-04-22
EP1325751A1 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
BR9508031A (pt) Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do composto
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
PA8486001A1 (es) Composiciones de celecoxib
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
BR0107246A (pt) Agentes diazabicìclicos ativos no sistema nervoso central
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
ES2192839T3 (es) Timosina beta 4 oxidada.
BR0111034A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
CY1114133T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ
SE0101932D0 (sv) Pharmaceutical combinations
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
SE9802208D0 (sv) Novel compounds
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
NO20031650D0 (no) Nye legemidler for leversykdommer
PT866791E (pt) Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
SE0003476D0 (sv) Compounds
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
AR028772A1 (es) 5-aminoalquil-pirazol[4,3-d] pirimidinas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application